Department of Ophthalmology, Medical University of Białystok, Białystok, Poland.
Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Białystok, Białystok, Poland.
PLoS One. 2023 Oct 19;18(10):e0293143. doi: 10.1371/journal.pone.0293143. eCollection 2023.
Age-related macular degeneration is the primary cause of irreversible blindness in developed countries, whereas the global prevalence of osteoporosis-a major public health problem-is 19.7%. Both diseases may coincide in populations aged >50 years, leading to serious health deterioration and decreased quality of life.
This study aimed to analyze the relationship between age-related macular degeneration and osteopenia, defined as decreased bone mineral density, in the Polish population.
Participants were derived from the population-based Bialystok PLUS Study. Randomized individuals were stratified into two groups, those with age-related macular degeneration (AMD-1 group) or without age-related macular degeneration (AMD-0 group). Using a cutoff value of -1.0 to identify low bone mass, participants with femoral bone mineral density T-scores above -1.0 were assigned to the normal reference, and those with T-scores below -1.0 were assigned to the osteopenia category. Among 436 Caucasian participants aged 50-80 years (252 women, 184 men), the prevalence of age-related macular degeneration was 9.9% in women and 12.0% in men. Decreased bone mineral density based on T-scores was observed in 36.9% of women and in 18.9% of men. Significant differences in femoral bone mineral density between the AMD-0 and AMD-1 groups were detected only in men (mean difference [95% confidence interval] = 0.11 (0.02; 0.13); p = 0.012 for femoral bone mineral density, and 0.73 [0.015; 0.94]; p = 0.011 for the femoral T-score). No associations were observed between bone mineral density and age-related macular degeneration in women.
Decreased femoral bone mineral density may be associated with a higher risk of age-related macular degeneration in men, but a causal link remains unclear.
年龄相关性黄斑变性是发达国家致盲的主要原因,而骨质疏松症——一个主要的公共卫生问题——在全球的患病率为 19.7%。这两种疾病在>50 岁的人群中可能同时存在,导致严重的健康恶化和生活质量下降。
本研究旨在分析波兰人群中年龄相关性黄斑变性与骨质疏松症(定义为骨密度降低)之间的关系。
参与者来自基于人群的比亚韦斯托克 PLUS 研究。随机分层的个体分为两组,一组有年龄相关性黄斑变性(AMD-1 组),另一组没有年龄相关性黄斑变性(AMD-0 组)。使用-1.0 的截值来识别低骨量,股骨骨密度 T 评分高于-1.0 的参与者被分配到正常参考组,T 评分低于-1.0 的参与者被分配到骨质疏松症组。在 436 名 50-80 岁的白种人参与者中(252 名女性,184 名男性),女性中年龄相关性黄斑变性的患病率为 9.9%,男性中为 12.0%。根据 T 评分,女性中骨密度降低的发生率为 36.9%,男性中为 18.9%。仅在男性中,AMD-0 组和 AMD-1 组之间的股骨骨密度存在显著差异(平均差异[95%置信区间]为 0.11(0.02;0.13);p=0.012 用于股骨骨密度,0.73(0.015;0.94);p=0.011 用于股骨 T 评分)。在女性中,未观察到骨密度与年龄相关性黄斑变性之间存在关联。
股骨骨密度降低可能与男性年龄相关性黄斑变性的风险增加相关,但因果关系尚不清楚。